Boston Scientific Corporation (BSX)

73,57 +0,31 (+0,42 %) À partir de 10:35AM EDT. Marché ouvert.

Boston Scientific Corporation

300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
508 683 4000
https://www.bostonscientific.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 48 000

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Michael F. Mahoney	Chairman, President & CEO	4,83M	12,98M	1965
Mr. Daniel J. Brennan	Executive VP & CFO	2,15M	1,71M	1966
Mr. Joseph M. Fitzgerald	Executive VP & Group President of Cardiology	1,84M	4,7M	1964
Mr. Jeffrey B. Mirviss	Executive VP & President of Peripheral Interventions	1,44M	S.O.	1966
Mr. Arthur Crosswell Butcher	Executive VP and Group President of MedSurg & Asia Pacific	1,49M	626,04k	1971
Mr. David J. Roux	Independent Director	135k	S.O.	1957
Mr. John Bradley Sorenson	Executive Vice President of Global Operations	S.O.	S.O.	1968
Ms. Emily Woodworth	Senior VP, Global Controller & Chief Accounting Officer	S.O.	S.O.	1978
Ms. Jodi Euerle Eddy	Senior VP and Chief Information & Digital Officer	S.O.	S.O.	1974
Mr. Jonathan R Monson	Senior VP of Investor Relations	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Boston Scientific Corporation en date du 1 avril 2024 est 9. Les scores principaux sont Audit : 10; Société : 9; Droits des actionnaires : 8; Compensation : 7.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.